These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17877201)

  • 21. [The role of BK polyomavirus in the development of hemorrhagic cystitis after hematopoietic stem cell transplantation].
    Xie Y; Han Y; Wu DP
    Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):746-9. PubMed ID: 19080201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
    Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn BM; Ringden O; Winiarski J; Ljungman P; Dalianis T
    Bone Marrow Transplant; 2008 Apr; 41(8):737-42. PubMed ID: 18176615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation.
    Cesaro S; Facchin C; Tridello G; Messina C; Calore E; Biasolo MA; Pillon M; Varotto S; Brugiolo A; Mengoli C; Palù G
    Bone Marrow Transplant; 2008 Feb; 41(4):363-70. PubMed ID: 17982496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration.
    Trotman J; Nivison-Smith I; Dodds A
    Bone Marrow Transplant; 1999 Apr; 23(8):797-801. PubMed ID: 10231142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
    Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for severe hemorrhagic cystitis following BMT.
    Seber A; Shu XO; Defor T; Sencer S; Ramsay N
    Bone Marrow Transplant; 1999 Jan; 23(1):35-40. PubMed ID: 10037048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
    Yamamoto R; Kusumi E; Kami M; Yuji K; Hamaki T; Saito A; Murasgihe N; Hori A; Kim SW; Makimoto A; Ueyama J; Tanosaki R; Miyakoshi S; Mori S; Morinaga S; Heike Y; Taniguchi S; Masuo S; Takaue Y; Mutou Y
    Bone Marrow Transplant; 2003 Dec; 32(11):1089-95. PubMed ID: 14625581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients.
    Bogdanovic G; Priftakis P; Giraud G; Dalianis T
    Anticancer Res; 2006; 26(2B):1311-8. PubMed ID: 16619539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multivariate Analysis of Factors Influencing Recovery from Hemorrhagic Cystitis after Allo-HSCT].
    Zhang B; Hu CY; Yu D; Zhang HX; Yan DM; Sang W; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):976-982. PubMed ID: 31204964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
    Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: retrospective analysis in a single institution.
    Arai Y; Maeda T; Sugiura H; Matsui H; Jo T; Ueda T; Okada K; Kawata T; Onishi T; Mizutani C; Ueda Y
    Hematology; 2012 Jul; 17(4):207-14. PubMed ID: 22944099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.
    Ruggeri A; Roth-Guepin G; Battipaglia G; Mamez AC; Malard F; Gomez A; Brissot E; Belhocine R; Vekhoff A; Lapusan S; Isnard F; Legrand O; Gozlan J; Boutolleau D; Ledraa T; Labopin M; Rubio MT; Mohty M
    Transpl Infect Dis; 2015 Dec; 17(6):822-30. PubMed ID: 26354178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematuria due to adenoviral infection in bone marrow transplant recipients.
    Bil-Lula I; Ussowicz M; Rybka B; Wendycz-Domalewska D; Ryczan R; Gorczyńska E; Kałwak K; Woźniak M
    Transplant Proc; 2010 Nov; 42(9):3729-34. PubMed ID: 21094847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
    Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation.
    Mori Y; Miyamoto T; Kato K; Kamezaki K; Kuriyama T; Oku S; Takenaka K; Iwasaki H; Harada N; Shiratsuchi M; Abe Y; Nagafuji K; Teshima T; Akashi K
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):458-65. PubMed ID: 21810401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients.
    Dalianis T; Ljungman P
    Anticancer Res; 2011 Mar; 31(3):939-44. PubMed ID: 21498717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.